Class Action Filed Against Bath & Body Works for Securities Fraud

Written by Emily J. Thompson, Senior Investment Analyst

Source: Globenewswire

Updated: 2d ago

0mins

BBWI+3.64%

Should l Buy BBWI?

Source: Globenewswire

Class Action Initiated: Kessler Topaz Meltzer & Check, LLP has filed a securities fraud class action against Bath & Body Works, Inc., concerning investor losses from June 4, 2024, to November 19, 2025, highlighting serious issues regarding the company's financial transparency.
Investor Loss Claims: The lawsuit seeks recovery of investment losses for affected investors under federal securities laws, indicating significant misstatements about the company's operations and prospects, which may lead to a decline in investor confidence.
Financial Guidance Errors: The complaint alleges that Bath & Body Works failed to disclose that its strategy of pursuing “adjacencies, collaborations, and promotions” was not effectively growing its customer base, resulting in the company being unlikely to meet its previously issued financial guidance, potentially impacting future performance.
Lead Plaintiff Process: Investors have until March 16, 2026, to apply to be appointed as lead plaintiffs in the class action, representing all affected investors in the litigation, underscoring the importance of legal processes in protecting investor rights.

Trade with 70% Backtested Accuracy

Stop guessing "Should I Buy BBWI?" and start using high-conviction signals backed by rigorous historical data.

BBWI

$23.05+Infinity%1D

Analyst Views on BBWI

Wall Street analysts forecast BBWI stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for BBWI is 20.14 USD with a low forecast of 15.00 USD and a high forecast of 26.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

14 Analyst Rating

4 Buy

10 Hold

0 Sell

Moderate Buy

Current: 22.240

Low

15.00

Averages

20.14

High

26.00

Current: 22.240

Low

15.00

Averages

20.14

High

26.00

Deutsche Bank

Hold

maintain

$21

2026-01-08

Reason

Deutsche Bank

Price Target

$21

AI Analysis

2026-01-08

maintain

Hold

Reason

Deutsche Bank resumed coverage of Bath & Body Works with a Hold rating and $21 price target. The firm resumed coverage of global brands, off-price, and specialty beauty retail. Following a "surprisingly strong" year for retail, Deutsche is entering 2026 with optimism as it anticipates a "volatile but broadly risk-on" macro environment, the analyst tells investors in a research note. The firm sees solid top-line trends, particularly in the first half of the year, due to easier weather comparisons and a boost in tax refunds.

UBS

Jay Sole

Neutral

maintain

$17 -> $21

2026-01-08

Reason

UBS

Jay Sole

Price Target

$17 -> $21

2026-01-08

maintain

Neutral

Reason

UBS analyst Jay Sole raised the firm's price target on Bath & Body Works to $21 from $17 and keeps a Neutral rating on the shares. CY26 EPS upside for Softline stocks is expected to be driven by a stronger-than-expected U.S. consumer and an underappreciated "Health & Wellness 2.0" trend, with estimates at least 4% above consensus for 16 names, the analyst tells investors in a research note. Earnings momentum is projected to extend into CY27, with EPS forecasts averaging about 5% above consensus, the firm adds.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for BBWI

Unlock Now

About BBWI

Bath & Body Works, Inc. is a global omnichannel retailer focused on personal care and home fragrance. The Company offers a range of fragrances for the body and home, including selling collections for 3-wick candles, home fragrance diffusers, fine fragrance mists, liquid hand soaps, body lotions and body creams. It delivers customers their fragrances in multiple forms and categories. The Company sells merchandise through its retail stores in the United States and Canada, and through its Websites and other channels, under the Bath & Body Works, White Barn and other brand names. The Company’s international business is conducted through franchise, license and wholesale partners. It provides in-store experiences at more than 1,890 Company-operated Bath & Body Works locations in the United States and Canada, more than 525 international franchised locations and an online storefront at bathandbodyworks.com. Additionally, it offers a buy online pick-up in-store (BOPIS) option.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

Class Action Lawsuit Filed Against Bath & Body Works, Inc.

5 hours agoGlobenewswire

Lawsuit Background: Bath & Body Works, Inc. (NYSE: BBWI) is facing a class action lawsuit for alleged violations of federal securities laws, targeting the company and its officers on behalf of investors who purchased securities between June 4, 2024, and November 19, 2025.
Allegations Details: The complaint alleges that throughout the class period, defendants made materially false and misleading statements while failing to disclose adverse facts about the company's business and prospects, misleading investors regarding its financial health.
Financial Guidance Missteps: The lawsuit claims that the company's strategy of pursuing

Class Action Notice for Bath & Body Works Securities

1 day agoGlobenewswire

Class Action Notice: Rosen Law Firm reminds investors who purchased Bath & Body Works securities between June 4, 2024, and November 19, 2025, that they must apply to be lead plaintiff by March 16, 2026, to participate in the class action and potentially receive compensation.
Lawsuit Background: The lawsuit alleges that Bath & Body Works made materially false statements during the Class Period, failing to disclose that its strategy of 'adjacencies, collaborations, and promotions' was not effectively growing its customer base, resulting in investor losses.
Law Firm Advantages: Rosen Law Firm specializes in securities class actions and has recovered over $438 million for investors in 2019 alone, demonstrating its successful track record and resource advantages, urging investors to select experienced legal counsel wisely.
Investor Action Recommendations: Investors can visit Rosen Law Firm's website or call the toll-free number for more information on how to participate in the lawsuit, ensuring they have appropriate legal representation in the class action.

Multiple Companies Face Class Action Lawsuits

2 days agoGlobenewswire

Varonis Systems Lawsuit: During the class period from February 4, 2025, to October 28, 2025, Varonis is accused of failing to sustain its annual recurring revenue growth, which has severely undermined investor confidence in the company's prospects, with a lead plaintiff deadline set for March 9, 2026.
Ardent Health Allegations: Ardent Health faces accusations from July 18, 2024, to November 12, 2025, of inaccurately assessing the collectability of accounts receivable, leading to significant misrepresentation of its financial health, with investors required to act by March 9, 2026.
CoreWeave Risk Disclosure: CoreWeave is alleged to have overstated its ability to meet customer demand during the period from March 28, 2025, to December 15, 2025, failing to adequately disclose the risks associated with reliance on a single third-party data center, which could materially impact revenue, with a lead plaintiff deadline of March 13, 2026.
Bath & Body Works Financial Misrepresentation: Bath & Body Works is accused of failing to meet its financial guidance during the period from June 4, 2024, to November 19, 2025, with its brand collaboration strategy not effectively growing its customer base, requiring investor action by March 16, 2026.